What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock

Troendle retains a $3.27 billion combined stake, representing 19% of the market cap, with the majority of holdings controlled through Medpace Investors, LLC.

CryptoAlerta — análise de criptomoedas e mercado em tempo real